Fig. 3From: The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing dataUBE2C expression in subtypes of ductal BRCA and normal tissues from Oncomine. The contrast between UBE2C expression in invasive ductal BRCA and normal breast tissues was more obvious (P = 0.006, P = 7.08E−10, a, b) than that in ductal BRCA in situ and the matched normal tissues (P = 0.022, P = 4.79E−5, c, d)Back to article page